Provenienza dei contatti di primo grado di Graham Scott
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Chemicals: Specialty | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Graham Scott tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
GLOBAL GAMING TECHNOLOGIES CORP. | Financial Conglomerates | Director/Board Member | |
HEMOGENYX PHARMACEUTICALS PLC | Biotechnology | Chief Operating Officer | |
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chief Operating Officer | |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Medical/Nursing Services | Chief Operating Officer | |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chief Operating Officer | |
180 LIFE SCIENCES CORP. | Pharmaceuticals: Major | Chief Operating Officer | |
Durango Gold Corp.
Durango Gold Corp. Precious MetalsNon-Energy Minerals Durango Gold Corp. mines for gold and silver ores. The CEOs are Fernando Berdegue, Fernando Berdegu de Cima. The American company was founded in 2013. | Precious Metals | Director/Board Member |
Statistiche
Distribuzione geografica
Canada | 5 |
Stati Uniti | 4 |
Regno Unito | 2 |
Settori
Health Technology | 5 |
Finance | 2 |
Consumer Services | 2 |
Health Services | 2 |
Non-Energy Minerals | 2 |
Posizioni
Director/Board Member | 8 |
Chief Operating Officer | 6 |
Chief Executive Officer | 3 |
Director of Finance/CFO | 2 |
Corporate Secretary | 2 |
Contatti più connessi
Insiders | |
---|---|
Lawrence Pemble | 8 |
Craig Auringer | 2 |
- Borsa valori
- Insiders
- Graham Scott
- Connessioni Società